e-learning
resources
Milan 2017
Wednesday, 13.09.2017
Monitoring asthma control
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Weight-adjusted Intravenous Reslizumab Attenuates Airway Eosinophilia in Severe Asthmatics compared to 100 mg Subcutaneous Mepolizumab
M. Mukherjee (Hamilton, ON, Canada)
Source:
International Congress 2017 – Monitoring asthma control
Session:
Monitoring asthma control
Session type:
Poster Discussion
Number:
4768
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Mukherjee (Hamilton, ON, Canada). Weight-adjusted Intravenous Reslizumab Attenuates Airway Eosinophilia in Severe Asthmatics compared to 100 mg Subcutaneous Mepolizumab. 4768
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Can we treat Exercise Induced Laryngeal Obstruction with inhaled ipratropiumbromide?
Source: Virtual Congress 2021 – What's new in respiratory problems in rare and systemic diseases
Year: 2021
Creatine Supplementation Augments Chronic Allergic Airway Inflammation and Remodelling: from Mice to Human Evidence
Source: International Congress 2018 – COPD: novel pathological mechanisms in the airway epithelium
Year: 2018
Inhaled Molgramostim Therapy in Autoimmune Pulmonary Alveolar Proteinosis (APAP)
Source: Virtual Congress 2020 – ALERT: Pneumothorax, cough, PAH, alveolar proteinosis
Year: 2020
Effectiveness of Nebulized Budesonide in Iranian Patients with Asthma Attack
Source: Virtual Congress 2020 – Advances in asthma treatment
Year: 2020
The Effect of Bronchial Thermoplasty on Lung Function in Severe Asthma Patients
Source: International Congress 2018 – New perspectives on asthma, cough and laryngeal obstruction
Year: 2018
Aerobic Training Improves Pulmonary and Systemic Inflammatory and Fibrotic Response in Asthmatics
Source: Virtual Congress 2021 – A multidisciplinary approach to the management of chronic respiratory diseases
Year: 2021
Assessment of Efficacy Omalizumab Retreatment in Patients With Severe Asthma
Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures
Year: 2018
LATE-BREAKING ABSTRACT: Blood Eosinophil Count as a Biomarker of ICS Effectiveness in Reducing Exacerbation Rates in COPD
Source: International Congress 2014 – Latest insights in airway diseases
Year: 2014
Blood Eosinophils Correlate With Severe Exacerbations in Frequent Exacerbator Phenotype of COPD
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018
Progressive Phenotype in Chronic Hypersensitivity Pneumonitis
Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020
LATE-BREAKING ABSTRACT: Reduction in exacerbations with mepolizumab in severe eosinophilic asthma: MENSA study
Source: International Congress 2014 – The future has started: emerging potentials for personalised asthma treatment
Year: 2014
A new Humanized Mouse Model for Idiopathic Pulmonary Fibrosis and Effects of Nintedanib Treatment
Source: International Congress 2018 – Progress in basic and translational research on idiopathic interstitial pneumonias
Year: 2018
Methylprednisolone pulse therapy in Acute Exacerbations of Idiopathic Pulmonary Fibrosis
Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis
Year: 2020
Bronchial Rheoplasty Increases Distal Airway Volume in Chronic Bronchitis
Source: International Congress 2019 – Advances in COPD pharmacology
Year: 2019
Cost Effectiveness Of Bronchial Thermoplasty For Treatment Of Severe Asthma Patients In Scotland
Source: International Congress 2017 – Does economisation of medicine transfer into benefits for patients?
Year: 2017
Chronic Airway Inflammation promotes de novo Sensitization to Inhaled Allergen by Persistent Activation of Dendritic Cells
Source: Research Seminar 2009 - Molecular and Cellular aspects of Chronic Lung Disease
Year: 2009
Low Level of Airway Mucin 2 Predict Severe Exacerbations in Patients with Severe Chronic Obstructive Pulmonary Disease
Source: International Congress 2017 – COPD biomarkers
Year: 2017
Effects of inhaled salmeterol/fluticasone on lung function in patients with bronchiectasis
Source: International Congress 2014 – Novel evidence relating to respiratory treatment development
Year: 2014
Dupilumab Effect on Lung Function in Patients With Uncontrolled, Moderate-to-Severe Asthma With an Allergic Phenotype
Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma
Year: 2019
Interaction between RPL554 and glycopyrronium bromide in small human airways
Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept